Search results for: 'software for clinical studi'

Frost & Sullivan expects the global MedTech managed vendor services market to witness significant changes over the next few years, driven by the increasing technology adoption by managed equipment services (MES), multi-vendor services (MVS), and professional service providers. They will do so due to the transformations in healthcare facilities, the...

Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline asse...

05 Aug 2024  |  Global  |  Technology Research

CGT Research Outlook and Technology Growth Opportunities

CGT Landscape Assessment

Infographics

×

The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and clinical success rates has led to the growing demand for the development of new technology platforms, manufacturing capabilities, a...

Healthcare providers and payers are operating under the pressure of rising healthcare costs, demand for better health outcomes, and the need to improve the digital patient experience. All major healthcare stakeholders acknowledge the need to invest in digital infrastructure, and provider-payer collaboration capabilities to facilitate cross-cont...

13 Jun 2023  |  North America  |  Market Research

US Healthcare Data Analytics, 2023

Competitive Intensity is Driving Innovation Among Healthcare Data Analytics Vendors

Infographics

×

This report offers a comprehensive analysis of the US healthcare data analytics market. The analysis focuses on solutions for payers and providers (including physician practices and hospitals). Solutions for the life sciences segment, pharmaceutical companies, and the public sector have been excluded. This study categorizes healthcare data analytic...

A mass spectrometer (MS) determines atom/molecule mass by measuring the mass-to-charge ratio of its ions. It consists of four basic components: a sample inlet, an ionization source, a mass analyzer, and a detector. It is largely used in University research laboratories and government research institutions; pharmaceutical, biotechnology/biopharmaceu...

Conventional visualization methods that depend on two-dimensional (2D) medical images have been fraught with challenges such as difficulty in interpreting the information due to the static nature of the content and lack of availability of volumetric data. To address these limitations, imaging preferences of the medical community are shifting toward...

HIMSS 2026, held in Las Vegas, brought together 24,000+ stakeholders and 900+ exhibitors, underscoring the growing urgency for healthcare organizations to translate digital investments into measurable outcomes amid cost pressures, workforce shortages, and rising care complexity. Discussions at the event highlighted a clear shift from innovation-led...

This analysis explores the transformation of healthcare from reactive disease treatment toward proactive, continuous, and personalized health management driven by AI, digital health, and predictive intelligence. Rising chronic disease burdens, aging populations, and escalating healthcare costs are accelerating demand for early detection, continuous...